Announcements Trials
Browse Landscape

Phase

Phase 2 5

Status

Completed 4Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4Breast 1

Conditions

Colorectal Neoplasms 3Triple Negative Breast Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Breast Neoplasms 1

Interventions

pembrolizumab 302Carboplatin 155Nivolumab 154Cisplatin 139Cyclophosphamide 130Paclitaxel 127Magnetic Resonance Spectroscopy 98Specimen Handling 95Radiotherapy 90Gemcitabine 87Dexamethasone 83Biopsy 81Ipilimumab 78Docetaxel 75Doxorubicin 75Rituximab 69Etoposide 67atezolizumab 61durvalumab 60Lenalidomide 59Radiation 59Pemetrexed 58Taxes 57Bevacizumab 54Prednisone 54fludarabine 54olaparib 53Cytarabine 49Vincristine 49Fluorouracil 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Has results × Panitumumab × 1 year × Clear all
NCT03693807 2026-02-06

A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
35 enrolled 14 charts
Gastrointestinal

Colorectal Neoplasms, Cholangiocarcinoma

NCT03983993 2026-01-05

NIPAVect

Emory University

Phase 2 Active not recruiting
26 enrolled 8 charts
Gastrointestinal

Colorectal Neoplasms

NCT02593175 2025-11-06

Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC

M.D. Anderson Cancer Center

Phase 2 Completed
43 enrolled 8 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01312857 2025-10-09

Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
75 enrolled 12 charts
Gastrointestinal

Colorectal Neoplasms

NCT03442569 2025-07-01

PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
56 enrolled 13 charts
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡